Chiesi Group’s 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices

In 2023, Chiesi, a research-oriented international biopharmaceutical group headquartered in Parma, with 31 affiliates worldwide, showcased the efficacy of its operating model centred around shared value, sustainability, and high ethical standards.

Scroll to Top